Plant-Based Treatments for MRSA: How They Work and Future Possibilities

Greg Howard
23rd June, 2024

Plant-Based Treatments for MRSA: How They Work and Future Possibilities

Fluorescence microscopy reveals the potent antibacterial action of extracts from Rheum palmatum (b), Arctium lappa (c), and Paeonia suffructicosa (d), which kill MRSA by inflicting severe cellular damage, including distorted shapes (i), compromised membranes (ii), and disorganized DNA (iii), in contrast to the intact, untreated cells (a).

Image adapted from: He et al. / CC BY (Source)

Key Findings

  • Researchers at Queen's University Belfast tested 68 Chinese medicinal plants for their ability to fight MRSA
  • Three plants, Rheum palmatum L., Arctium lappa L., and Paeonia suffructicosaas Andr., showed strong anti-MRSA properties
  • These plants were safe for human cells and worked by disrupting MRSA's cell wall and membrane
  • Combining these plant extracts with the antibiotic vancomycin significantly boosted the antibiotic's effectiveness
Rising resistance to antimicrobials, particularly methicillin-resistant Staphylococcus aureus (MRSA), presents a significant global health challenge. A recent study conducted by Queen's University Belfast has evaluated 68 Chinese medicinal plants for their potential to combat MRSA[1]. This study aims to identify new antimicrobial solutions to address the growing issue of drug-resistant pathogens. The researchers assessed the antimicrobial efficacy of these plants by determining their minimum inhibitory concentration (MIC) against MRSA. Safety profiles were evaluated using human colorectal adenocarcinoma (Caco-2) and hepatocellular carcinoma (HepG2) cells. Mechanistic insights were obtained through fluorescence and transmission electron microscopy (FM and TEM). Additionally, the study investigated the synergistic effects of these plant extracts with vancomycin using the Fractional Inhibitory Concentration Index (FICI). Among the 68 plants tested, Rheum palmatum L., Arctium lappa L., and Paeonia suffructicosaas Andr. emerged as potential candidates with potent anti-MRSA properties. These plants demonstrated an impressive low MIC of 7.8 µg/mL, comparable to the 2 µg/mL MIC of vancomycin, which served as the antibiotic control. Importantly, these candidates exhibited significant safety profiles when evaluated on Caco-2 and HepG2 cells. Even at 16 times the MIC, cell viability ranged from 83.3% to 95.7%, highlighting their potential safety. The study revealed that these medicinal plants act against MRSA through multiple mechanisms. FM and TEM showed that the plants disrupted the cell wall and membrane, interfered with nucleoids, and induced morphological alterations resembling pseudo-multicellular structures in MRSA. These diverse actions suggest that the plants can effectively combat MRSA through various pathways, reducing the likelihood of resistance development. The synergy between vancomycin and the three plant extracts was particularly noteworthy. The FICI values indicated a synergistic effect, with the aqueous extract of R. palmatum at 1/4 MIC significantly reducing the vancomycin MIC from 2 µg/mL to 0.03 µg/mL, a remarkable 67-fold decrease. This finding suggests that combining these plant extracts with vancomycin could enhance the antibiotic's effectiveness, potentially reviving its use against resistant strains. This study aligns with previous research on the benefits of using whole plant extracts and traditional medicine for treating infectious diseases. For example, there is evidence that crude plant extracts often have greater antiplasmodial activity than isolated constituents at equivalent doses[2]. This could be due to positive interactions between different components of the plants, such as pharmacodynamic synergy and pharmacokinetic interactions. Similarly, traditional Chinese medicine (TCM) has shown unique advantages in treating infectious diseases, including pathogen inhibition and organ recovery during severe and drug-resistant infections[3]. Moreover, essential oils (EOs) have been recognized for their antimicrobial properties, providing an alternative to conventional antibiotics[4]. The current study's findings on the antimicrobial efficacy of Chinese medicinal plants further support the potential of natural products as therapeutic agents. However, as with EOs, further experiments are necessary to confirm their pharmacological effectiveness and determine potential toxic effects in in vivo models. In conclusion, this study from Queen's University Belfast provides new insights into the mechanistic actions and pleiotropic antibacterial effectiveness of Rheum palmatum L., Arctium lappa L., and Paeonia suffructicosaas Andr. against MRSA. These findings offer robust evidence for the potential use of these medicinal plants as standalone treatments or in conjunction with antibiotics to combat antimicrobial resistance, particularly against MRSA.

MedicineHealthBiochem

References

Main Study

1) Phytotherapeutic potential against MRSA: mechanisms, synergy, and therapeutic prospects.

Published 22nd June, 2024

https://doi.org/10.1186/s13020-024-00960-8

Related Studies

2) Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions.

https://doi.org/10.1186/1475-2875-10-S1-S4

3) Prevention and treatment of infectious diseases by traditional Chinese medicine: a commentary.

https://doi.org/10.1111/apm.12928

4) Chemical composition, cytotoxicity, antimicrobial and antifungal activity of several essential oils.

https://doi.org/10.1080/14786419.2015.1060592


Related Articles

An unhandled error has occurred. Reload 🗙